摘要
目的:观察慢萎散对慢性萎缩性胃炎(CAG)的临床治疗作用。方法:将177例患者随机分为治疗组和对照组,治疗组(87例)口服中药慢萎散治疗;对照组(90例)口服奥美拉唑钠肠溶片、克拉霉素胶囊及阿莫西林分散片。观察2组的临床症状、胃镜表现、病理组织学改变及幽门螺杆菌(Hp)根除率。结果:治疗组的临床疗效、胃镜表现、病理组织学改变、Hp根除率均优于对照组(P<0.05)。结论:慢萎散对CAG患者临床症状、病理组织学及Hp根除率具有明显的改善作用。
OBJECTIVE： To observe clinical effects of Manweisan in the treatment of chronic atrophic gastritis. METHODS： 117 patients with chronic atrophic gastritis were randomly divided into treatment group and control group. Treatment group （87 cases） was given Manweisan, while control group （90 cases） was given Omeprazole sodium enteric-coated tablet, Clarithromycin capsule and Amoxicillin dispersible tablet orally. Clinical symptoms, endoscopic feature and histological scores and Hp eradication rate were evaluated. RESULTS： The therapeutic efficacy, endoscopic feature, histological scores and Hp eradication rate of treatment group were significantly better than those of control group （P〈0.05）, respectively. CONCLUSION： Manweisan can effectively improve the clinical symptoms, pathological transformation and Hp eradication rate in patients with chronic atrophic gastritis.
出处
《中国药房》
CAS
CSCD
北大核心
2011年第35期3335-3337,共3页
China Pharmacy
关键词
慢性萎缩性胃炎
慢萎散
临床观察
Chronic atrophic gastritis
Manweisan
Clinical obserration
